We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KMB:PYTHKIMBERLY-CLARK CORPORATION / US DOLLAR Analysis

Data as of 2026-05-19 - not real-time

$96.10

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kimberly‑Clark (KMB) is trading at $96.10, well below its 20‑day and 50‑day SMAs (97.33 and 97.76) and far beneath the 200‑day SMA of $109.29, indicating a sustained bearish price trend. The RSI sits at 45, suggesting neutral momentum, while the MACD histogram remains negative, reinforcing downside pressure. Volume has been decreasing, and the 30‑day volatility is high at 23.5%, which could amplify short‑term price swings. Fundamentally, revenue growth is modest at 2.7% and profit margins are respectable (operating margin 19.6%, net margin 12.8%), yet the company carries an extreme debt‑to‑equity ratio of 371% and a payout ratio of 98%, raising concerns about dividend sustainability. The dividend yield is attractive at 5.3%, but cash on hand ($0.54 B) is dwarfed by total debt ($7.11 B). Valuation metrics are mixed: the forward P/E of 12.68 looks cheap, but the price‑to‑book of 17.76 and a DCF‑derived fair value of $26.55 suggest severe overvaluation. Analyst consensus remains neutral (hold) with a median target of $110, implying modest upside if the stock can rebound from its current support around $94.67. Recent Q1 2026 earnings showed a 15% YoY revenue decline and a slight EPS miss, underscoring the near‑term earnings pressure. The pending acquisition of Kenvue could provide a catalyst for medium‑term growth, but integration risk and the high leverage profile remain key headwinds. Overall, the stock appears positioned for a short‑term hold with caution, while medium‑term prospects hinge on successful execution of the Kenvue deal and improvement in cash generation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical setup (price below all SMAs)
  • Decreasing volume and high short‑term volatility
  • Recent earnings miss and revenue contraction

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential upside from Kenvue acquisition integration
  • Forward earnings estimate improvement (forward EPS $7.58)
  • Attractive dividend yield if sustainability improves

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong brand portfolio in consumer defensive sector
  • High leverage and near‑full dividend payout limiting flexibility
  • Valuation disparity between market price and DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth2.70%
Profit Margin12.80%
P/E Ratio18.6
ROE111.73%
ROA10.16%
Debt/Equity371.26
P/B Ratio17.8
Op. Cash Flow$3.2B
Free Cash Flow$1.1B

Technical Analysis

TrendBearish
RSI45.1
Support$94.67
Resistance$100.49
MA 20$97.33
MA 50$97.76
MA 200$109.29
MACDBearish
VolumeDecreasing
Fear & Greed Index89.2

Valuation

Fair Value$26.55
Target Price$114.27
Upside/Downside18.91%
GradeOvervalued
TypeValue
Dividend Yield5.30%

Risk Assessment

Beta0.12
Volatility23.47%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.